258 related articles for article (PubMed ID: 21244554)
41. Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.
Verrotti A; Coppola G; Manco R; Ciambra G; Iannetti P; Grosso S; Balestri P; Franzoni E; Chiarelli F
Seizure; 2007 Apr; 16(3):271-5. PubMed ID: 17204435
[TBL] [Abstract][Full Text] [Related]
42. Levetiracetam monotherapy for the treatment of infants with epilepsy.
Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
Seizure; 2018 Mar; 56():73-77. PubMed ID: 29453114
[TBL] [Abstract][Full Text] [Related]
43. Levetiracetam reduces the frequency of interictal epileptiform discharges during NREM sleep in children with ADHD.
Bakke KA; Larsson PG; Eriksson AS; Eeg-Olofsson O
Eur J Paediatr Neurol; 2011 Nov; 15(6):532-8. PubMed ID: 21683631
[TBL] [Abstract][Full Text] [Related]
44. Levetiracetam-induced reversible autistic regression.
Camacho A; Espín JC; Nuñez N; Simón R
Pediatr Neurol; 2012 Jul; 47(1):65-7. PubMed ID: 22704022
[TBL] [Abstract][Full Text] [Related]
45. Levetiracetam monotherapy for primary generalised epilepsy.
Cohen J
Seizure; 2003 Apr; 12(3):150-3. PubMed ID: 12651079
[TBL] [Abstract][Full Text] [Related]
46. Can High-Dose Levetiracetam Be Safe? A Case Report of Prolonged Accidental High-Dose Levetiracetam Administration and Review of the Literature.
Kartal A
Clin Neuropharmacol; 2017; 40(5):217-218. PubMed ID: 28682928
[TBL] [Abstract][Full Text] [Related]
47. [Experience with levetiracetam in childhood epilepsy].
Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
[TBL] [Abstract][Full Text] [Related]
48. Levetiracetam monotherapy for newly diagnosed epilepsy patients.
Alsaadi TM; Thieman C
Seizure; 2003 Apr; 12(3):154-6. PubMed ID: 12651080
[TBL] [Abstract][Full Text] [Related]
49. [Follow-up study on levetiracetam monotherapy in children with epilepsy].
Gao ZJ; Jiang YW
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):711-4. PubMed ID: 19102836
[TBL] [Abstract][Full Text] [Related]
50. A prospective multi-centre open label study of the use of levetiracetam as add-on treatment in patients with epilepsy and intellectual disabilities.
Beavis J; Meek A; Felce D; Kerr M
Seizure; 2009 May; 18(4):279-84. PubMed ID: 19084433
[TBL] [Abstract][Full Text] [Related]
51. The efficacy, tolerability and safety of levetiracetam therapy in a pediatric population.
Tekgül H; Gencpinar P; Çavuşoğlu D; Dündar NO
Seizure; 2016 Mar; 36():16-21. PubMed ID: 26874856
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use.
Mandelbaum DE; Bunch M; Kugler SL; Venkatasubramanian A; Wollack JB
J Child Neurol; 2005 Jul; 20(7):590-4. PubMed ID: 16159526
[TBL] [Abstract][Full Text] [Related]
53. [The retrospective study of efficacy and safety of levetiracetam as an add-on treatment of epilepsy in children].
Aĭvazian SO; Shiriaev IuS
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(10 Pt 1):33-8. PubMed ID: 22500310
[TBL] [Abstract][Full Text] [Related]
54. Continuation rates of levetiracetam in children from the EULEVp cohort study.
Dureau-Pournin C; Pédespan JM; Droz-Perroteau C; Lavernhe G; Mann M; Pollet C; Robinson P; Jové J; Moore N; Fourrier-Réglat A;
Eur J Paediatr Neurol; 2014 Jan; 18(1):19-24. PubMed ID: 24035600
[TBL] [Abstract][Full Text] [Related]
55. Effect of levetiracetam on behavioral problems in pervasive developmental disorder children with epilepsy.
Kanemura H; Sano F; Ohyama T; Sugita K; Aihara M
Eur J Paediatr Neurol; 2014 Jul; 18(4):482-8. PubMed ID: 24703761
[TBL] [Abstract][Full Text] [Related]
56. Brand name to generic substitution of levetiracetam in patients with epilepsy.
Gha-Hyun L; Dae SJ
Seizure; 2018 Aug; 60():127-131. PubMed ID: 29960217
[TBL] [Abstract][Full Text] [Related]
57. Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
Sheinberg R; Heyman E; Dagan Z; Youngster I; Kohn E; Gandelman-Marton R; Berkovitch M
Pediatr Neurol; 2015 Jun; 52(6):624-8. PubMed ID: 25791893
[TBL] [Abstract][Full Text] [Related]
58. An initial experience with therapeutic drug monitoring of levetiracetam as reported from a pediatric clinical setting in India.
Mathew BS; Fleming DH; Thomas M; Prabha R; Saravanakumar K
Neurol India; 2012; 60(2):146-9. PubMed ID: 22626693
[TBL] [Abstract][Full Text] [Related]
59. Levetiracetam Monotherapy in Children with Epilepsy: A Systematic Review.
Weijenberg A; Brouwer OF; Callenbach PM
CNS Drugs; 2015 May; 29(5):371-82. PubMed ID: 26013703
[TBL] [Abstract][Full Text] [Related]
60. Levetiracetam monotherapy for treatment of structural epilepsy in dogs: 19 cases (2010-2015).
Kelly D; Raimondi F; Shihab N
Vet Rec; 2017 Oct; 181(15):401. PubMed ID: 28847876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
